vatalanib has been researched along with Cancer of the Thyroid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eilles, C; Grimm, D; Infanger, M; Kossmehl, P; Kurth, E; Schoenberger, J | 1 |
Barber, SE; Bekele, BN; Jasser, SA; Kim, S; Mandal, M; Myers, JN; Yazici, YD | 1 |
2 other study(ies) available for vatalanib and Cancer of the Thyroid
Article | Year |
---|---|
Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study.
Topics: Adenocarcinoma, Follicular; Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Line, Tumor; Extracellular Matrix Proteins; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Thyroglobulin; Thyroid Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2004 |
Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Carcinoma; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Drug Therapy, Combination; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Thyroid Neoplasms | 2006 |